Screener
Vaxcyte, Inc. PCVX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
FAQ
- What is Vaxcyte, Inc.'s current ratio?
- Vaxcyte, Inc. (PCVX) reported current ratio of 7.5× in Q1 2026.
- How has Vaxcyte, Inc.'s current ratio changed year-over-year?
- Vaxcyte, Inc.'s current ratio decreased by 57.7% year-over-year, from 17.7× to 7.5×.
- What is the long-term trend for Vaxcyte, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s current ratio has grown at a -1.0% compound annual growth rate (CAGR), from 8.3× to 7.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Vaxcyte, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude